11 Best Buy-the-Dip Stocks to Buy Now

5. Healthpeak Properties, Inc. (NYSE:DOC)

Closing Price as on April 28: $17.75

52-week Low: $17.33

Number of Hedge Fund Holders: 37

Healthpeak Properties, Inc. (NYSE:DOC) is a fully integrated real estate investment trust (REIT). Ronald Kamdem from Morgan Stanley maintained a “Buy” rating on the company’s stock with a price objective of $24.00. The analyst’s rating is backed by a combination of factors, which include the company’s performance as well as strategic financial maneuvers. The analyst highlighted recent stock buybacks to the tune of ~$94 million. This exhibits confidence in Healthpeak Properties, Inc. (NYSE:DOC)’s valuation and offers potential downside protection. Notably, the company repurchased 5.1 million shares at a weighted average share price of $18.50 for an aggregate total of $94 million during Q1 and through April 24, 2025.

Elsewhere, analyst Juan C. Sanabria from BMO Capital maintained a “Buy” rating on the company’s stock, keeping the price target at $24.00. The analyst’s rating is backed by factors demonstrating healthy performance and strategic actions of Healthpeak Properties, Inc. (NYSE:DOC). Sanabria believes that the company remains proactive in capitalizing on market conditions (repurchasing $94 million worth of shares). This implies a strategic approach to enhance shareholder value. Despite the political uncertainties, Healthpeak Properties, Inc. (NYSE:DOC)’s lab leasing activities are strong, possessing a healthy tenant retention rate and favourable leasing spreads. Subsequent to Q1 and via April 24, 2025, the company executed 175,000 square feet of Lab leases with signed letters of intent on an additional 400,000 square feet.

Aristotle Capital Boston, LLC, an investment advisor, released its Q4 2024 investor letter. Here is what the fund said:

“Healthpeak Properties, Inc. (NYSE:DOC), is a healthcare-focused real estate investment trust (REIT) that develops, owns and manages medical office buildings, senior housing assets and life science facilities. Following an industry-wide life sciences building boom that created a supply/demand imbalance, DOC is poised to benefit from improved lease rates with its properties as excess industry capacity is absorbed. A solid fundamental backdrop for the demographically driven senior housing portfolio and stability within its medical office building portfolio should allow the company to produce improved financial performance over the next several years.”